What does Aligos Therapeutics, Inc. (ALGS) do?

Aligos Therapeutics, Inc. (ALGS) is a publicly traded company in the Healthcare sector.

What sector does ALGS operate in?

Aligos Therapeutics, Inc. operates in the Healthcare, specifically within the Biological Products, (No Diagnostic Substances) industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ALGS earnings analysis?

AlphaOS publishes an earnings intelligence page for Aligos Therapeutics, Inc. (ALGS) covering results, guidance context, and AI-assisted analysis. See /stocks/ALGS/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ALGS

Aligos Therapeutics, Inc.

Healthcare · Biological Products, (No Diagnostic Substances)

$5.51Sep 25, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Aligos Therapeutics, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -100% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -100% YoY in Q2 FY2026

Pipeline evidence · 1d ago

ALGS's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ALGS.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ALGS earnings analysis

Reported figures for Aligos Therapeutics, Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 27, 2026

What happened recently for Aligos Therapeutics, Inc. (ALGS) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 25, 2026 at $5.51.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

Aligos Therapeutics, Inc. (ALGS)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Aligos Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biological Products, (No Diagnostic Substances)
Market cap:: $234.77M
Revenue:: $2.83M

ALGS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Aligos Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.